Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.

Sarah L. Anderson

TitleClinical Associate Professor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-PEDS
Phone303/724-5926
ORCID ORCID Icon0000-0002-8420-9527 Additional info

    Collapse Biography 
    Collapse education and training
    University of Colorado at Boulder, Boulder, COBA05/2003Biochemistry
    University of Colorado School of Pharmacy, Denver, COPharmD05/2007
    Denver Health Medical Center, Denver, COPGY107/2008Pharmacy Practice
    University of Colorado School of Pharmacy, Aurora, COPGY207/2009Ambulatory Care/Family Medicine
    Collapse awards and honors
    2021Alumni Spotlight, Phi Lambda Sigma
    2020Adult Medicine Practice & Research Network (PRN) - Mentoring Award, American College of Clinical Pharmacy
    2020Fellow (FASHP), American Society of Health-System Pharmacists
    2019Next Generation Pharmacist Health-System Pharmacist Award, Pharmacy Times and Parata Systems
    2019Pharmacist of the Year, Colorado Pharmacists Society
    2018Adult Medicine Practice & Research Network (PRN) – Clinical Practice Award, American College of Clinical Pharmacy
    2018Phi Delta Chi Distinguished Alumni Award, Phi Delta Chi Sigma Chapter
    2018Team Award: Safety, Quality, and Service, Denver Health Medical Center
    2017Fellow (FCCP), American College of Clinical Pharmacy
    2017Leading by Example Award, Denver Health Medical Center
    2017Compassionate Care Award, Denver Health Medical Center
    2017Finalist; Next-Generation Pharmacist Health-System Pharmacist award, Pharmacy Times and Parata Systems
    2016Most accessed paper, Pharmacotherapy
    2015Faculty Preceptor of the Year , University of Colorado Skaggs School of Pharmacy & Pharmaceutical Sciences
    2015Star Award: Identification and resolution of drug dosing error in Micromedex, Denver Health Medical Center
    2014Patient Safety & Quality Pillar Award, Denver Health Medical Center
    2013Best Practices Award, American Society of Health-System Pharmacists
    2013Distinguished Young Pharmacist Award, Colorado Pharmacists Society and Pharmacists Mutual
    2013Star Award: Participant in the anticoagulation on-call program, Denver Health Medical Center
    2012Team Award: Access Improvement, Denver Health Medical Center
    2011Team Award: Eastside Adult Diabetes 3/3 Bundle Improvement, Denver Health Medical Center
    2010Team Award: Establishment of Ambulatory Clinical Pharmacy Services, Denver Health Medical Center
    2010Customer Service Award, Denver Health Medical Center Eastside Adult Clinic
    2010Phi Delta Chi Distinguished Alumni Award, Phi Delta Chi Sigma Chapter
    2009Adult Medicine PRN New Investigator Award, American College of Clinical Pharmacy
    2022Authored one of AJHP’s Top 25 Articles of 2021, American Journal of Health-System Pharmacists
    2022Authored one of JACCP’s Top-Cited Articles for 2021, Journal of the American College of Clinical Pharmacy

    Collapse Overview 

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Anderson SL, Marrs JC. Tirzepatide for type 2 diabetes. Drugs Context. 2023; 12. PMID: 37664792.
      View in: PubMed
    2. Anderson SL, Marrs JC. Diabetes: how to manage cardiovascular risk in secondary prevention patients. Drugs Context. 2022; 11. PMID: 35775074.
      View in: PubMed
    3. Gosser R, Anderson S, Blaszczyk A, Jen C, Bhatt S. In It for the Long Haul: Post-Acute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2. J Pharm Pract. 2023 Oct; 36(5):1048-1051. PMID: 35356830.
      View in: PubMed
    4. Nardolillo JA, Marrs JC, Anderson SL, Hanratty R, Saseen JJ. Retrospective cohort study of statin prescribing for primary prevention among people living with HIV. JRSM Cardiovasc Dis. 2021 Jan-Dec; 10:20480040211031068. PMID: 34290861.
      View in: PubMed
    5. White BM, Anderson SL, Marrs JC. Antihypertensive prescribing patterns and hypertension control in females of childbearing age. Am J Health Syst Pharm. 2021 07 09; 78(14):1317-1322. PMID: 33848330.
      View in: PubMed
    6. Cornelison P, Marrs JC, Anderson SL. Clinical Pharmacist Outreach to Increase Statin Use for Patients with Cardiovascular Disease in a Safety-Net Healthcare System. Am Health Drug Benefits. 2021 Jun; 14(2):63-69. PMID: 34267861.
      View in: PubMed
    7. Anderson SL, Bianco J, DeRemer CE. Adapting ambulatory care learning environments in response to the COVID-19 pandemic. Am J Health Syst Pharm. 2021 03 05; 78(6):467-471. PMID: 33483738.
      View in: PubMed
    8. Clements JN, Emmons RP, Anderson SL, Chow M, Coon S, Irwin AN, Mukherjee M, Sease JM, Thrasher K, Witek SR. Current and Future State of Quality Metrics and Performance Indicators in Comprehensive Medication Management for Ambulatory Care Pharmacy Practice. J Am Coll Clin Pharm. 2021.
      View Publication
    9. Anderson SL, Bassetti M, Mangoni AA. Drugs in Context Editorial: Review of 2020 and what lies ahead in therapeutic interventions. Drugs Context. 2021; 10. PMID: 33542739.
      View in: PubMed
    10. Marrs JC, Anderson SL. Ertugliflozin in the treatment of type 2 diabetes mellitus. Drugs Context. 2020; 9. PMID: 33293984.
      View in: PubMed
    11. Marrs JC, Anderson SL. Bempedoic acid for the treatment of dyslipidemia. Drugs Context. 2020; 9. PMID: 32922503.
      View in: PubMed
    12. Olin JL, Anderson SL, Hellwig TR, Jenkins AT, Craven R, Touchette DR. Characterization of Clinical Pharmacist and Hospitalist Collaborative Relationships. J Am Coll Clin Pharm. 2020; 3:1413–1422.
      View Publication
    13. Anderson SL, Marrs JC, Chachas CR, Cichon BS, Cizmic AD, Calderon BB, Vlasimsky TB. Evaluation of a Pharmacist-Led Intervention to Improve Statin Use in Persons with Diabetes. J Manag Care Spec Pharm. 2020 Jul; 26(7):910-917. PMID: 32584671.
      View in: PubMed
    14. Stranges PM, Jackevicius CA, Anderson SL, Bondi DS, Danelich I, Emmons RP, Englin EF, Hansen ML, Nys C, Phan H, Philbrick AM, Rager M, Schumacher C, Sean S. Role of clinical pharmacists and pharmacy support personnel in transitions of care. J Am Coll Clin Pharm. 2020; (3):532-545.
      View Publication
    15. Anderson SL, Beutel TR, Trujillo JM. Oral semaglutide in type 2 diabetes. J Diabetes Complications. 2020 04; 34(4):107520. PMID: 31952996.
      View in: PubMed
    16. Anderson SL, Marrs JC. Can Direct Oral Anticoagulants Be Used for Stroke Prevention Among Patients with Valvular Atrial Fibrillation? Curr Cardiol Rep. 2019 08 31; 21(10):118. PMID: 31473836.
      View in: PubMed
    17. Al-Omar LT, Anderson SL, Cizmic AD, Vlasimsky TB. Implementation of a Pharmacist-Led Diabetes Management Protocol. Am Health Drug Benefits. 2019 Feb; 12(1):14-20. PMID: 30972149.
      View in: PubMed
    18. Anderson SL, Marrs JC. Sacubitril/valsartan: evaluation of safety and efficacy as an antihypertensive treatment. Drugs Context. 2018; 7:212542. PMID: 30116284.
      View in: PubMed
    19. Marrs JC, Anderson SL, Gabriel C. Role of aldosterone receptor antagonists in heart failure with preserved ejection fraction. Clinical Medicine Insights: Therapeutics. 2018; 10:1-9.
      View Publication
    20. Anderson SL, Marrs JC. A Review of the Role of the Pharmacist in Heart Failure Transition of Care. Adv Ther. 2018 03; 35(3):311-323. PMID: 29488151.
      View in: PubMed
    21. Anderson SL, Marrs JC. Direct oral anticoagulant use in valvular heart disease. Clinical Medicine Insights: Therapeutics. 2018; 10:1-6.
      View Publication
    22. Anderson SL, Trujillo JM, Anderson JE, Tanenberg RJ. Switching basal insulins in type 2 diabetes: practical recommendations for health care providers. Postgrad Med. 2018 Mar; 130(2):229-238. PMID: 29260929.
      View in: PubMed
    23. Anderson SL, Marrs JC. Antihyperglycemic Medications and Cardiovascular Risk Reduction. Eur Endocrinol. 2017 Aug; 13(2):86-90. PMID: 29632614.
      View in: PubMed
    24. Anderson SL, Kattappuram RS, Marrs JC, Joseph NM. Intentional Brodifacoum Ingestion. Am J Med. 2017 Jan; 130(1):e27-e28. PMID: 27591180.
      View in: PubMed
    25. Anderson SL, Trujillo JM. Basal Insulin Use With GLP-1 Receptor Agonists. Diabetes Spectr. 2016 Aug; 29(3):152-60. PMID: 27574369.
      View in: PubMed
    26. Norman JL, Anderson SL. Novel class of medications, orexin receptor antagonists, in the treatment of insomnia - critical appraisal of suvorexant. Nat Sci Sleep. 2016; 8:239-47. PMID: 27471419.
      View in: PubMed
    27. Rhyne DN, Anderson SL, Gedde M, Borgelt LM. Effects of Medical Marijuana on Migraine Headache Frequency in an Adult Population. Pharmacotherapy. 2016 05; 36(5):505-10. PMID: 26749285.
      View in: PubMed
    28. Anderson SL, Trujillo JM. Lixisenatide in type 2 diabetes: latest evidence and clinical usefulness. Ther Adv Chronic Dis. 2016 Jan; 7(1):4-17. PMID: 26770666.
      View in: PubMed
    29. Rhyne DN, Anderson SL. Suvorexant in insomnia: efficacy, safety and place in therapy. Ther Adv Drug Saf. 2015 Oct; 6(5):189-95. PMID: 26478806.
      View in: PubMed
    30. Anderson SL. Strategies for successfully navigating the pharmacy residency interview process. Am J Health Syst Pharm. 2015 Jun 01; 72(11 Suppl 1):S33-5. PMID: 25991593.
      View in: PubMed
    31. Wobeter BR, Anderson SL, Marrs JC. Characterization of diastolic dysfunction heart failure following an acute hospitalization for heart failure in an urban, underserved population. Ther Adv Cardiovasc Dis. 2015 Oct; 9(5):267-74. PMID: 25767213.
      View in: PubMed
    32. Anderson S, Christensen S. Hypersensitivity reaction to omeprazole in a patient treated for Helicobacter pylori. Therap Adv Gastroenterol. 2015 Mar; 8(2):101-4. PMID: 25729434.
      View in: PubMed
    33. Fosmire Rundgren EW, Anderson SL, Marrs JC. Response to comment "Evaluation of aspirin use for primary prevention in diabetic patients". Ann Pharmacother. 2015 Feb; 49(2):262-3. PMID: 25583942.
      View in: PubMed
    34. Anderson SL. Dapagliflozin efficacy and safety: a perspective review. Ther Adv Drug Saf. 2014 Dec; 5(6):242-54. PMID: 25436106.
      View in: PubMed
    35. Fosmire Rundgren EW, Anderson SL, Marrs JC. Evaluation of aspirin use in patients with diabetes receiving care in community health. Ann Pharmacother. 2015 Feb; 49(2):170-7. PMID: 25288823.
      View in: PubMed
    36. King WM, Saseen JJ, Anderson SL. Characterization of diabetes risk factors in patients prescribed chronic statin therapy. Ther Adv Chronic Dis. 2014 Sep; 5(5):206-11. PMID: 25177478.
      View in: PubMed
    37. Woodward HN, Anderson SL. Once-weekly albiglutide in the management of type 2 diabetes: patient considerations. Patient Prefer Adherence. 2014; 8:789-803. PMID: 24926194.
      View in: PubMed
    38. Anderson SL, Vande Griend JP. Quetiapine for insomnia: A review of the literature. Am J Health Syst Pharm. 2014 Mar 01; 71(5):394-402. PMID: 24534594.
      View in: PubMed
    39. Anderson SL, Marrs JC. Probable Interaction Between Warfarin and Divalproex Sodium. J Pharm Technol. 2014 Feb; 30(1):8-12. PMID: 34860893.
      View in: PubMed
    40. Anderson SL, Borgelt LM. Case report: Risk of uterine perforation from IUDs is greatest during postpartum period. Am Fam Physician. 2013 Nov 15; 88(10):634-6. PMID: 24364477.
      View in: PubMed
    41. Anderson SL, Marrs JC, Vande Griend JP, Hanratty R. Implementation of a clinical pharmacy specialist-managed telephonic hospital discharge follow-up program in a patient-centered medical home. Popul Health Manag. 2013 Aug; 16(4):235-41. PMID: 23537153.
      View in: PubMed
    42. Toussaint KA, Watson K, Marrs JC, Sturpe DA, Anderson SL, Haines ST. Prevalence of and factors that influence board certification among pharmacy practice faculty at United States colleges and schools of pharmacy. Pharmacotherapy. 2013 Jan; 33(1):105-11. PMID: 23307551.
      View in: PubMed
    43. Anderson SL, Trujillo JM, McDermott M, Saseen JJ. Determining predictors of response to exenatide in type 2 diabetes. J Am Pharm Assoc (2003). 2012 Jul-Aug; 52(4):466-71. PMID: 22825226.
      View in: PubMed
    44. Anderson SL, Marrs JC. Dapagliflozin for the treatment of type 2 diabetes. Ann Pharmacother. 2012 Apr; 46(4):590-8. PMID: 22433611.
      View in: PubMed
    45. Vande Griend JP, Anderson SL. Histamine-1 receptor antagonism for treatment of insomnia. J Am Pharm Assoc (2003). 2012; 52(6):e210-9. PMID: 23229983.
      View in: PubMed
    46. Anderson SL, Trujillo JM. Association of pancreatitis with glucagon-like peptide-1 agonist use. Ann Pharmacother. 2010 May; 44(5):904-9. PMID: 20371755.
      View in: PubMed
    Anderson's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (125) concept(s)
    _
    Co-Authors Expand Description
    See all (7) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department

    Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)